Author

Izabela Coimbra Ibraim

University of California, IrvineORCID 0000-0003-1617-5369Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Assay:proteomics· 1

Frequent Co-Authors

Afshana QuadiriiD· 2 shared Anthony B. Nesburn· 2 shared Baruch D. Kuppermann· 2 shared Daniel Gil· 2 shared Hawa VahediD· 2 shared Jeffrey B. Ulmer· 2 shared Lbachir BenMohamediD· 2 shared Swayam PrakashiD· 2 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 44 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Afshana QuadiriORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologyHuman Vaccines & ImmunotherapeuticsPeer-reviewedJul 4, 2025

A Pan-Beta-Coronavirus Vaccine Bearing Conserved and Asymptomatic B- and T-Cell Epitopes Protect Against Highly Pathogenic Delta and Highly Transmissible Omicron SARS-CoV-2 Variants of Concern.

Hawa Vahed, Swayam Prakash, Afshana Quadiri…·Lbachir BenMohamed

This paper develops a multi-epitope vaccine targeting conserved B- and T-cell epitopes from SARS-CoV-2, showing protection against Delta and Omicron variants in a mouse model.

9 citationstop 2%

mouseproteomics

𝕏 PostBluesky

ImmunologybioRxivPreprintFeb 14, 2024

A Broad-Spectrum Multi-Antigen mRNA/LNP-Based Pan-Coronavirus Vaccine Induced Potent Cross-Protective Immunity Against Infection and Disease Caused by Highly Pathogenic and Heavily Spike-Mutated SARS-CoV-2 Variants of Concern in the Syrian Hamster Model

Swayam Prakash, Nisha Rajeswari Dhanushkodi, Mahmoud Singer…·Lbachir BenMohamed

This paper develops a multi-antigen mRNA/LNP-based pan-CoV vaccine that provides cross-protective immunity against multiple SARS-CoV-2 variants in a hamster model.

10 citations

mouseexperimental assay

𝕏 PostBluesky